NCT03194100View on ClinicalTrials.gov

Serum METRNL Concentration in Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Diabetes Mellitus, Type 2
All Listed Sponsors
lead

Chungnam National University Hospital

OTHER

NCT03194100 - Serum METRNL Concentration in Type 2 Diabetes | Biotech Hunter | Biotech Hunter